Iovance Biotherapeutics, Inc. IOVA Gross Profit
Gross Profit at other companies
Other financials
Where this comes from
Calculated from Iovance Biotherapeutics, Inc.’s reported figures.
The official record: Iovance Biotherapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Iovance Biotherapeutics, Inc.'s gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Iovance Biotherapeutics, Inc.'s gross profit?
- Iovance Biotherapeutics, Inc. (IOVA) reported gross profit of $28.93M in Q1 2026.
- How has Iovance Biotherapeutics, Inc.'s gross profit changed year-over-year?
- Iovance Biotherapeutics, Inc.'s gross profit increased by 337.8% year-over-year, from $6.61M to $28.93M.
- What is the long-term trend for Iovance Biotherapeutics, Inc.'s gross profit?
- Over 2 years (2023 to 2025), Iovance Biotherapeutics, Inc.'s gross profit has grown at a 2200.2% compound annual growth rate (CAGR), from $156K to $82.54M.
- What does gross profit mean?
- Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.